These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19778560)

  • 1. Simultaneous delivery of doxorubicin and immunostimulatory CpG motif to tumors using a plasmid DNA/doxorubicin complex in mice.
    Mizuno Y; Naoi T; Nishikawa M; Rattanakiat S; Hamaguchi N; Hashida M; Takakura Y
    J Control Release; 2010 Jan; 141(2):252-9. PubMed ID: 19778560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable CpG DNA hydrogels for sustained delivery of doxorubicin and immunostimulatory signals in tumor-bearing mice.
    Nishikawa M; Mizuno Y; Mohri K; Matsuoka N; Rattanakiat S; Takahashi Y; Funabashi H; Luo D; Takakura Y
    Biomaterials; 2011 Jan; 32(2):488-94. PubMed ID: 20932569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-delivery of doxorubicin and plasmid by a novel FGFR-mediated cationic liposome.
    Xiao W; Chen X; Yang L; Mao Y; Wei Y; Chen L
    Int J Pharm; 2010 Jun; 393(1-2):119-26. PubMed ID: 20416367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the content of unmethylated CpG dinucleotides in plasmid DNA on the sustainability of transgene expression.
    Mitsui M; Nishikawa M; Zang L; Ando M; Hattori K; Takahashi Y; Watanabe Y; Takakura Y
    J Gene Med; 2009 May; 11(5):435-43. PubMed ID: 19291673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of CpG motifs on gene expression and clearance kinetics of aerosol administered polyethylenimine (PEI)-plasmid DNA complexes in the lung.
    Lesina E; Dames P; Rudolph C
    J Control Release; 2010 Apr; 143(2):243-50. PubMed ID: 20074600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of mannosylated cationic liposomes/ immunostimulatory CpG DNA complex for effective inhibition of peritoneal dissemination in mice.
    Kuramoto Y; Kawakami S; Zhou S; Fukuda K; Yamashita F; Hashida M
    J Gene Med; 2008 Apr; 10(4):392-9. PubMed ID: 18181219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunostimulatory CpG-modified plasmid DNA enhances IL-12, TNF-alpha, and NO production by bovine macrophages.
    Shoda LK; Kegerreis KA; Suarez CE; Mwangi W; Knowles DP; Brown WC
    J Leukoc Biol; 2001 Jul; 70(1):103-12. PubMed ID: 11435492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal administration of CpG DNA lipoplex prevents pulmonary metastasis in mice.
    Zhou S; Kawakami S; Yamashita F; Hashida M
    Cancer Lett; 2010 Jan; 287(1):75-81. PubMed ID: 19660857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral delivery of IL-18 naked DNA induces T-cell activation and Th1 response in a mouse hepatic cancer model.
    Chang CY; Lee J; Kim EY; Park HJ; Kwon CH; Joh JW; Kim SJ
    BMC Cancer; 2007 May; 7():87. PubMed ID: 17519043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR9-dependent systemic interferon-beta production by intravenous injection of plasmid DNA/cationic liposome complex in mice.
    Yoshida H; Nishikawa M; Yasuda S; Mizuno Y; Toyota H; Kiyota T; Takahashi R; Takakura Y
    J Gene Med; 2009 Aug; 11(8):708-17. PubMed ID: 19462411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA and its cationic lipid complexes induce CpG motif-dependent activation of murine dendritic cells.
    Yoshinaga T; Yasuda K; Ogawa Y; Nishikawa M; Takakura Y
    Immunology; 2007 Mar; 120(3):295-302. PubMed ID: 17199803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopharmacological and antitumor effects of second-generation immunomodulatory oligonucleotides containing synthetic CpR motifs.
    Wang D; Li Y; Yu D; Song SS; Kandimalla ER; Agrawal S
    Int J Oncol; 2004 Apr; 24(4):901-8. PubMed ID: 15010828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab' fragments and single chain Fv.
    Cheng WW; Allen TM
    J Control Release; 2008 Feb; 126(1):50-8. PubMed ID: 18068849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting of immunostimulatory DNA cures experimental visceral leishmaniasis through nitric oxide up-regulation and T cell activation.
    Datta N; Mukherjee S; Das L; Das PK
    Eur J Immunol; 2003 Jun; 33(6):1508-18. PubMed ID: 12778468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs.
    Yew NS; Zhao H; Wu IH; Song A; Tousignant JD; Przybylska M; Cheng SH
    Mol Ther; 2000 Mar; 1(3):255-62. PubMed ID: 10933941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hepatic metastasis of the colon26 adenocarcinoma with an alpha-galactosylceramide, KRN7000.
    Nakagawa R; Motoki K; Ueno H; Iijima R; Nakamura H; Kobayashi E; Shimosaka A; Koezuka Y
    Cancer Res; 1998 Mar; 58(6):1202-7. PubMed ID: 9515806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cationized catalase-loaded hydrogel for growth inhibition of peritoneally disseminated tumor cells.
    Hyoudou K; Nishikawa M; Ikemura M; Kobayashi Y; Mendelsohn A; Miyazaki N; Tabata Y; Yamashita F; Hashida M
    J Control Release; 2007 Sep; 122(2):151-8. PubMed ID: 17651858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of progression and metastasis of established colon tumors in mice by intravenous delivery of short interfering RNA targeting KITENIN, a metastasis-enhancing protein.
    Lee JH; Cho ES; Kim MY; Seo YW; Kho DH; Chung IJ; Kook H; Kim NS; Ahn KY; Kim KK
    Cancer Res; 2005 Oct; 65(19):8993-9003. PubMed ID: 16204073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes.
    Hatakeyama H; Akita H; Ishida E; Hashimoto K; Kobayashi H; Aoki T; Yasuda J; Obata K; Kikuchi H; Ishida T; Kiwada H; Harashima H
    Int J Pharm; 2007 Sep; 342(1-2):194-200. PubMed ID: 17583453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combined chemoimmunotherapy approach using a plasmid-doxorubicin complex.
    Bagalkot V; Lee IH; Yu MK; Lee E; Park S; Lee JH; Jon S
    Mol Pharm; 2009; 6(3):1019-28. PubMed ID: 19338265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.